Investigation of Antimicrobial activity of CTAB assisted hydrothermally derived Nano BaTiO
Materials Research Express, ISSN: 2053-1591, Vol: 6, Issue: 2
2019
- 13Citations
- 16Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
In spite of demonstrated application of nano barium titanate (BaTiO) in biomedical applications, its antibacterial/fungal activity and biocompatibility studies are hitherto unexplored. Present work reports synthesis, characterization and assessment of antimicrobial and hemolytic activity of nano BaTiO, owing to their potential futuristic biomedical applications. Nano BaTiO is prepared by surfactant (Hexadecyltrimethylammonium bromide, CTAB) assisted hydrothermal synthesis and is characterized by various analytical and spectroscopic techniques. Morphology of the as synthesized nano BaTiO is cubic in nature. Based on the characterization techniques, nano BaTiO synthesised using 15 mM CTAB (15-CBT) were considered for antimicrobial activity against various multidrug-resistant pathogens. Good inhibition activity was observed against C. albicans with MIC value of 0.37 mg ml and MFC of 0.75 mg ml. C. albicans treated with 10 mg of 15-CBT showed only 30% cell viability. The anticandidal mechanism of nano BaTiO against C. albicans was attributed to decrease in ergosterol biosynthesis leading to cell death. Further, only 3% hemolytic activity on human blood RBCs was observed at 0.2 mg ml of 15-CBT. The anticandidal activity and hemolytic activity of the synthesised nano BaTiO is systematically investigated and reported.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85057955974&origin=inward; http://dx.doi.org/10.1088/2053-1591/aaee3b; https://iopscience.iop.org/article/10.1088/2053-1591/aaee3b; http://iopscience.iop.org/article/10.1088/2053-1591/aaee3b/pdf; http://stacks.iop.org/2053-1591/6/i=2/a=025408/pdf; http://stacks.iop.org/2053-1591/6/i=2/a=025408?key=crossref.332fce13a372fa8f2fcec08d9cd5936c; http://iopscience.iop.org/article/10.1088/2053-1591/aaee3b; https://dx.doi.org/10.1088/2053-1591/aaee3b; https://validate.perfdrive.com/9730847aceed30627ebd520e46ee70b2/?ssa=e2567fb5-090e-47fc-a8b6-cc541e1e4038&ssb=06241208066&ssc=https%3A%2F%2Fiopscience.iop.org%2Farticle%2F10.1088%2F2053-1591%2Faaee3b&ssi=7a73dfed-cnvj-44dc-945b-0c8eb174e82c&ssk=botmanager_support@radware.com&ssm=67953632997323778502060658571361290&ssn=85ce2c2b82e7954a0f3112dd060812340ecee3e449d9-548a-4c5b-9d7576&sso=b068dcaf-f497241c935fe16f9536b8b6756c168c6799d3e27b5039e6&ssp=88271343511732145378173249031803631&ssq=90094807579127041564826405327443179982409&ssr=NTIuMy4yMTcuMjU0&sst=com.plumanalytics&ssu=&ssv=&ssw=&ssx=eyJyZCI6ImlvcC5vcmciLCJfX3V6bWYiOiI3ZjYwMDAyZTQ0OWQzYi0wMjNiLTQ3MjYtYjI4YS1kNDQ1MTk1NzZhNDUxNzMyMTI2NDA1MjY2MzQ5Mzg2NjEyLTQwYTVjYmYxYjg5NjJlMmY1MDIwMyIsInV6bXgiOiI3ZjkwMDBlZTJkZGI4My1mNjg3LTRkZjgtOWIxMy00NDQ5YjNkOGNmNzM1LTE3MzIxMjY0MDUyNjYzNDkzODY2MTItMGEyNDljNGYyMjBjYzVhNDUwMjAwIn0=
IOP Publishing
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know